View in EDS HTML Full Text PDF Full Text

Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).

Saved in:
Bibliographic Details
Title: Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
Authors: Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Matsubara T; Department of Orthopedics, Matsubara Mayflower Hospital, Hyogo, Japan., Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Amano K; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Ishiguro N; Aichi Developmental Disability Center, Aichi, Japan., Sugiyama E; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan., Yamaoka K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan., Genovese MC; Gilead Sciences Inc, Foster City, CA, USA., Kalunian K; Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, CA, USA., Walker D; Northumbria Healthcare, North Shields, UK., Gottenberg JE; Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France., de Vlam K; Department of Rheumatology, Universitair Ziekenhuis Leuven, Leuven, Belgium., Bartok B; Gilead Sciences Inc, Foster City, CA, USA., Pechonkina A; Gilead Sciences Inc, Foster City, CA, USA., Kondo A; Gilead Sciences K.K, Tokyo, Japan., Gao J; Gilead Sciences Inc, Foster City, CA, USA., Guo Y; Gilead Sciences Inc, Foster City, CA, USA., Tasset C; Galapagos NV, Mechelen, Belgium., Sundy JS; Gilead Sciences Inc, Foster City, CA, USA., Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Source: Modern rheumatology [Mod Rheumatol] 2022 Jan 05; Vol. 32 (1), pp. 59-67.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33274687
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Takeuchi+T%22">Takeuchi T</searchLink>; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Matsubara+T%22">Matsubara T</searchLink>; Department of Orthopedics, Matsubara Mayflower Hospital, Hyogo, Japan.<br /><searchLink fieldCode="AU" term="%22Atsumi+T%22">Atsumi T</searchLink>; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Amano+K%22">Amano K</searchLink>; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Ishiguro+N%22">Ishiguro N</searchLink>; Aichi Developmental Disability Center, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Sugiyama+E%22">Sugiyama E</searchLink>; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Yamaoka+K%22">Yamaoka K</searchLink>; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan.<br /><searchLink fieldCode="AU" term="%22Genovese+MC%22">Genovese MC</searchLink>; Gilead Sciences Inc, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kalunian+K%22">Kalunian K</searchLink>; Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Walker+D%22">Walker D</searchLink>; Northumbria Healthcare, North Shields, UK.<br /><searchLink fieldCode="AU" term="%22Gottenberg+JE%22">Gottenberg JE</searchLink>; Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22de+Vlam+K%22">de Vlam K</searchLink>; Department of Rheumatology, Universitair Ziekenhuis Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Bartok+B%22">Bartok B</searchLink>; Gilead Sciences Inc, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pechonkina+A%22">Pechonkina A</searchLink>; Gilead Sciences Inc, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kondo+A%22">Kondo A</searchLink>; Gilead Sciences K.K, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Gao+J%22">Gao J</searchLink>; Gilead Sciences Inc, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Guo+Y%22">Guo Y</searchLink>; Gilead Sciences Inc, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tasset+C%22">Tasset C</searchLink>; Galapagos NV, Mechelen, Belgium.<br /><searchLink fieldCode="AU" term="%22Sundy+JS%22">Sundy JS</searchLink>; Gilead Sciences Inc, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tanaka+Y%22">Tanaka Y</searchLink>; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100959226%22">Modern rheumatology</searchLink> [Mod Rheumatol] 2022 Jan 05; Vol. 32 (1), pp. 59-67.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100959226 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1439-7609 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214397595%22">14397595 </searchLink><i>NLM ISO Abbreviation: </i>Mod Rheumatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33274687
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14397595.2020.1859675
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 59
    Titles:
      – TitleFull: Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Takeuchi T
      – PersonEntity:
          Name:
            NameFull: Matsubara T
      – PersonEntity:
          Name:
            NameFull: Atsumi T
      – PersonEntity:
          Name:
            NameFull: Amano K
      – PersonEntity:
          Name:
            NameFull: Ishiguro N
      – PersonEntity:
          Name:
            NameFull: Sugiyama E
      – PersonEntity:
          Name:
            NameFull: Yamaoka K
      – PersonEntity:
          Name:
            NameFull: Genovese MC
      – PersonEntity:
          Name:
            NameFull: Kalunian K
      – PersonEntity:
          Name:
            NameFull: Walker D
      – PersonEntity:
          Name:
            NameFull: Gottenberg JE
      – PersonEntity:
          Name:
            NameFull: de Vlam K
      – PersonEntity:
          Name:
            NameFull: Bartok B
      – PersonEntity:
          Name:
            NameFull: Pechonkina A
      – PersonEntity:
          Name:
            NameFull: Kondo A
      – PersonEntity:
          Name:
            NameFull: Gao J
      – PersonEntity:
          Name:
            NameFull: Guo Y
      – PersonEntity:
          Name:
            NameFull: Tasset C
      – PersonEntity:
          Name:
            NameFull: Sundy JS
      – PersonEntity:
          Name:
            NameFull: Tanaka Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 01
              Text: 2022 Jan 05
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1439-7609
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Modern rheumatology
              Type: main
ResultId 1